At Voxel Rx we are developing the next generation of deep learning tools to better understand Alzheimer's Disease. Through this understanding, we aim to discover biomarkers for the diagnosis and early detection of neurological dysfunction so that treatment and intervention protocols can be established in this decade. Exponential problems require ideas that scale. Our tools leverage the latest cloud technologies including distributed GPU processing, as well as unsupervised feature learning and hierarchical forms of representation, that are capable of learning the discriminative, latent structure in data that is potentially unavailable to human physicians.